Skip to content

remdesivir

Southern Research investing in future of Birmingham

We are building a Center for Pandemic Resilience.
January 18, 2022

UAB expert updates BCA members on cornavirus pandemic

The Business Council of Alabama was briefed Thursday on the latest coronavirus pandemic news by Dr. Selwyn Vickers, the senior vice president for medicine and dean of the University of Alabama at Birmingham Medical School. “This virus really started from what we understand by our best estimates in 2019, probably December maybe a little earlier … Continued
August 31, 2020

Clinical trials of inhaled version of drug to treat COVID-19 to begin

The company behind the only drug approved by the U.S. Food and Drug Administration for treatment of COVID-19 announced Monday plans to begin clinical trials of an inhaled version of the drug, which, if proven beneficial, could make it easier to administer and treat people earlier.  In an open letter posted to Gilead Sciences website … Continued
June 23, 2020

FDA grants “emergency use authorization” for UAB-developed drug to treat COVID-19

The U.S. Food and Drug Administration on Friday issued an “emergency use authorization” for the drug remdesivir to treat COVID-19 patients, a fast-tracked approval of a drug that early clinical trial results show can speed recovery.   In a letter Friday to Gilead Sciences, the California-based drug-maker that owns the rights to the drug, the FDA … Continued
May 1, 2020

Alabama scientists are trying to help find treatments for COVID-19

The Alabama Department of Commerce announced Tuesday that a number of Alabama firms, research institutions and scientists have been mobilized in the international effort to fight the novel coronavirus, which has killed over ten thousand people this year. Huntsville’s Diatherix announced that it has developed a highly sensitive and specific assay, or test, for the … Continued
March 20, 2020